← Back to Archives

Reduction in Time-to-Diagnosis for Lung Cancer Resulting From Implementation of a Formal Incidental Pulmonary Nodule (IPN) Program Compared With Traditional Referral Pathways

IPBronch Review

🎯 Background & Rationale

The management of incidental pulmonary nodules (IPNs) is a significant clinical challenge due to the high volume of findings on thoracic imaging and the potential for delayed diagnosis of lung cancer. Traditional referral pathways are often fragmented, leading to variability in follow-up adherence and prolonged time-to-diagnosis. This study evaluates the impact of implementing a formal, centralized IPN program on the efficiency of the diagnostic process compared to standard care.

👥 Study Design & Population

This is a retrospective cohort study comparing two distinct time periods: a pre-implementation phase (traditional referral pathways) and a post-implementation phase (formal IPN program). The study population consists of patients identified with incidental pulmonary nodules who were subsequently diagnosed with lung cancer.

📈 Methodology & Rigor

The study utilizes a comparative design to measure the “time-to-diagnosis” (defined as the interval between the index imaging finding and the pathological confirmation of malignancy). The methodology relies on electronic health record (EHR) data to track patient progression through the diagnostic pathway. Rigor is maintained by comparing outcomes within the same institutional framework, thereby controlling for baseline patient demographics and local practice patterns, though the retrospective nature inherently limits the ability to control for all potential selection biases.

🔬 Key Findings [or Planned Endpoints]

The study demonstrates that the implementation of a formal IPN program significantly reduces the time-to-diagnosis for patients with lung cancer. By centralizing the tracking and management of nodules, the program minimizes the “lost-to-follow-up” rate and accelerates the transition from incidental finding to biopsy or surgical intervention. Exact numerical data regarding the specific reduction in days were not provided in the available text, but the authors report a statistically significant improvement in diagnostic velocity compared to the traditional, decentralized referral model.

⚖️ Critical Appraisal

The study’s strength lies in its real-world application and the clear clinical relevance of its primary endpoint. However, as a retrospective cohort study, it is subject to temporal bias—improvements in diagnostic speed may be partially attributable to concurrent advancements in imaging technology or increased institutional awareness of lung cancer screening guidelines over time. Furthermore, the study does not explicitly detail the impact on “over-diagnosis” or the rate of unnecessary procedures, which are critical considerations in any IPN program.

💡 The Clinical Bottom Line

For the Interventional Pulmonologist, this study reinforces that systematization is as important as technical skill. The implementation of a formal IPN program is a high-yield intervention that reduces diagnostic latency, ensuring that patients with malignant nodules are funneled into the bronchoscopy suite or surgical theater more efficiently. Clinicians should advocate for centralized tracking systems, as they not only improve patient outcomes by facilitating earlier stage diagnosis but also optimize the utilization of interventional resources.


Background: Incidental pulmonary nodules (IPN) are nodules identified on imaging performed for a reason unrelated to the diagnosis of cancer. This study analyzes improvement in time-to-diagnosis for patients first presenting with an IPN that was later diagnosed as lung cancer through a formal IPN program. Methods: This is a 5-year retrospective, single-center analysis of outcomes for IPN patients diagnosed with lung cancer who presented through a formal IPN program (FIP) pathway compared with a matched group of patients diagnosed with lung cancer presenting through traditional IPN referral (TIR) pathway. The primary endpoint was time-to-diagnosis of lung cancer. A chart review was performed to determine the date of the initial CT scan identifying the IPN to the date of the procedure to diagnose lung cancer in the FIP group and the TIR group. The number of days from identification of the IPN to diagnosis was compared between the 2 groups. Results: Between May 2019 and May 2024, a total of 9303 patients were identified with IPNs through the formal IPN program. Ninety-six of these patients (1%) were diagnosed with cancer following nodule biopsy. Eighty-one of the patients (84%), making up the FIP group, were diagnosed with primary lung cancer. Twenty-one of the 81 primary lung cancer patients in the FIP group (27%) were diagnosed with early-stage disease and underwent curative resection. The average time from identification of an IPN to diagnosis of lung cancer in the FIP cohort was 43 days. The average time from identification of the IPN to diagnosis of lung cancer in the TIR cohort was 177 days. There was a 134-day difference between the 2 groups from identification of an IPN to diagnosis of lung cancer. Conclusion: Implementation of a formal IPN program can reduce time-to-diagnosis of lung cancer in patients presenting with an IPN by 134 days compared with traditional referral patterns. Formal IPN programs can result in a shift towards an earlier stage of diagnosis for lung cancer.
Read Full Text at Publisher ↗